Sequential therapy with fludarabine, high dose cyclophosphamide, and rituximab improves the quality of response in patients with previously untreated chronic lymphocytic leukemia.

被引：0
|
作者：
Weiss, MA [1 ]
Lamanna, N [1 ]
Gencarelli, A [1 ]
Scheinberg, DA [1 ]
Maslak, PG [1 ]
Horgan, D [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Leukemia Serv, New York, NY 10021 USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5019
引用
收藏
页码：365B / 365B
页数：1
相关论文
共 50 条
  • [41] Low dose oral fludarabine plus cyclophosphamide in elderly patients with untreated and refractory chronic lymphocytic leukemia
    Forconi, Francesco
    Toraldo, F.
    Sozzi, E.
    Lenoci, M.
    Fabbri, A.
    Gozzetti, A.
    Tassi, M.
    Raspadori, D.
    Lauria, Francesco
    BLOOD, 2007, 110 (11) : 612A - 612A
  • [42] Chemoimmunotherapy with ofatumumab, fludarabine, and cyclophosphamide (O-FC) in previously untreated patients with chronic lymphocytic leukemia (CLL).
    Wierda, W. G.
    Kipps, T. J.
    Duerig, J.
    Griskevicius, L.
    Stilgenbauer, S.
    Mayer, J.
    Gorczyca, M.
    Andersen, M.
    Nielsen, T.
    Russell, C. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [43] Combination chemo-antibody therapy with fludarabine (F), cyclophosphamide (C) and rituximab (R) achieves a high CR rate in previously untreated chronic lymphocytic leukemia (CLL).
    Keating, MJ
    O'Brien, S
    Lerner, S
    Giles, F
    Andreeff, M
    Cortes, J
    Albitar, M
    Kantarjian, H
    BLOOD, 2000, 96 (11) : 514A - 514A
  • [44] Final results of lower dose fludarabine (F) and cyclophosphamide (C), and high dose rituximab (R), (FCR-Lite) for patients with untreated chronic lymphocytic leukemia (CLL)
    Tarhini, Ahmad A.
    Land, S.
    Pietragallo, L.
    Laman, A.
    Sulecki, M.
    Marks, S.
    Meisner, D.
    Schaefer, P. M.
    Foon, Kenneth A.
    BLOOD, 2007, 110 (11) : 606A - 607A
  • [45] LOW DOSE ORAL FLUDARABINE PLUS CYCLOPHOSPHAMIDE IN ELDERLY PATIENTS WITH UNTREATED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
    Forconi, F.
    Fabbri, A.
    Lenoci, M.
    Sozzi, E.
    Bocchia, M.
    Gozzetti, A.
    Tassi, M.
    Raspadori, D.
    Lauria, F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 37 - 37
  • [46] Efficiency of rituximab, fludarabine, and cyclophosphamide combination in chronic lymphocitic leukemia.
    Zagoskina, T. P.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2006, 51 (06): : 12 - 16
  • [47] The addition of rituximab to fludarabine significantly improves progression-free and overall survival in previously untreated chronic lymphocytic leukemia (CLL) patients.
    Byrd, JC
    Rai, KR
    Peterson, BL
    Appelbaum, FR
    Morrison, VA
    Kolitz, JE
    Shepherd, L
    Hines, JD
    Schiffer, CA
    Larson, RA
    BLOOD, 2003, 102 (11) : 73A - 73A
  • [48] Reduced-dose fludarabine, cyclophosphamide, and rituximab (FCR-Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia
    Mato, Anthony R.
    Foon, Kenneth A.
    Feldman, Tatyana
    Schuster, Stephen J.
    Svoboda, Jakub
    Chow, Kar Fai
    Valentinetti, Marisa
    Mrkulic, Mary
    Azzollini, Kelly
    Gadaleta, Gabriella
    Bhattacharyya, Pritish K.
    Zenreich, Joshua
    Pascual, Lauren-Nicole
    Yannotti, Kara
    Kdiry, Sabrina
    Howlett, Christina
    Strelec, Lauren
    Porter, David
    Bejot, Coleen
    Goy, Andre
    AMERICAN JOURNAL OF HEMATOLOGY, 2015, 90 (06) : 487 - 492
  • [49] Pentostatin and Rituximab Therapy for Previously Untreated Patients With B-Cell Chronic Lymphocytic Leukemia
    Kay, Neil E.
    Wu, Wenting
    Kabat, Brian
    LaPlant, Betsy
    Lin, Thomas S.
    Byrd, John C.
    Jelinek, Diane F.
    Greyer, Michael R.
    Zent, Clive S.
    Call, Timothy G.
    Shanafelt, Tait D.
    CANCER, 2010, 116 (09) : 2180 - 2187
  • [50] Interim results of the combination rituximab, fludarabine, cyclophosphamide and mitoxantrone (R-FCM) followed by rituximab maintenance in previously untreated chronic lymphocytic leukemia (CLL)
    Bosch, F.
    Muntanola, A.
    Villamor, N.
    Terol, M.
    Gonzalez-Barca, E.
    Ribera, J.
    Gonzalez, M.
    Abella, E.
    Delgado, J.
    Carbonell, F.
    Marco, J. Garcia
    Escoda, L.
    Ferrer, S.
    Monzo, E.
    Gonzalez, Y.
    de la Serna, J.
    Abrisqueta, P.
    Gine, E.
    Salamero, O.
    Montserrat, E.
    ANNALS OF ONCOLOGY, 2008, 19 : 194 - 194
12345